相关实验视频

Updated: Jun 6, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

发现新型的pyrrolo[2,3-d]pyrimidine衍生物作为抗癌剂:虚拟查和分子动态研究

S Dhiman^1,2, S Gupta¹, S K Kashaw³

¹Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, India.

SAR and QSAR in environmental research

|November 28, 2024

概括

开发出新型的pyrrolo[2,3-d]pyrimidine衍生物作为潜在的抗癌剂,通过抑制CDK4/6. 计算研究确定了对未来抗癌药物开发有前途的化合物.

科学领域:

药用化学医学化学
计算化学的计算化学
在瘤学瘤学.

背景情况:

循环素依赖性激酶 (CDK) 和循环素在人类癌症中经常存在失调.
抑制CDK4/6是一种有效的策略,用于控制细胞周期进展和癌细胞生长.

研究的目的:

设计和开发新的pyrrolo[2,3-d]pyrimidine (P2P) 衍生物作为潜在的针对CDK4/6.6的抗癌剂.
利用计算方法来识别强大的基于P2P的抑制剂.

主要方法:

基于原子和基于现场的3D定量结构-活动关系 (3D-QSAR) 建模.
在ZINC数据库的虚拟选中,使用药论假设 (HHHRR_1).
针对CDK4/6 (PDB ID: 5L2S) 的分子对接和分子动力学模拟.

主要成果:

3D-QSAR模型显示出良好的预测准确性 (Q2>0.73,r2>0.62).
分子对接确定了对CDK4/6抑制至关重要的关键氨基酸残留物 (例如VAL-101,HIE-100).
虚拟选和计数产生了有前途的化合物 (ZINC91325512,R1),具有有利的结合相互作用和稳定的分子动力学.

结论:

开发的P2P衍生物显示出潜在的新型抗癌药物,针对CDK4/6.
计算方法有效地指导了有前途的候选药物的识别.
对这些化合物的进一步研究可能会导致癌症治疗的新疗法策略.

关键词:

3D-QSAR 是一个3D-QSAR.这是一种CDK4抑制剂.分子动力学模拟模拟制药剂的映射制药剂的映射虚拟选是虚拟的选.

更多相关视频

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...